Effect of topographic comparison of electroencephalographic microstates on the diagnosis and prognosis prediction of patients with prolonged disorders of consciousness
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14421 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Yi Ling und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Consciousness, Brain. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Brain Project, The National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
The electroencephalography (EEG) microstates are indicative of fundamental information processing mechanisms, which are severely damaged in patients with prolonged disorders of consciousness (pDoC). We aimed to improve the topographic analysis of EEG microstates and explore indicators available for diagnosis and prognosis prediction of patients with pDoC, which were still lacking.
Methods
We conducted EEG recordings on 59 patients with pDoC and 32 healthy controls. We refined the microstate method to accurately estimate topographical differences, and then classify and forecast the prognosis of patients with pDoC. An independent dataset was used to validate the conclusion.
Results
Through optimized topographic analysis, the global explained variance (GEV) of microstate E increased significantly in groups with reduced levels of consciousness. However, its ability to classify the VS/UWS group was poor. In addition, the optimized GEV of microstate E exhibited a statistically significant decrease in the good prognosis group as opposed to the group with a poor prognosis. Furthermore, the optimized GEV of microstate E strongly predicted a patient's prognosis.
Conclusion
This technique harmonizes with the existing microstate analysis and exhibits precise and comprehensive differences in microstate topography between groups. Furthermore, this method has significant potential for evaluating the clinical prognosis of pDoC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China.
- Department of Neurology, First People's Hospital of Wenling, Zhejiang, China.
- Department of Rehabilitation, Hangzhou Mingzhou Brain Rehabilitation Hospital, Hangzhou, China.
- The MOE Frontier Science Center for Brain Science and Brain-Machine Integration, Zhejiang University, Hangzhou, China.
ORCID-Profile: Yi Ling, Zhengde Tao, Benyan Luo
Förderung
- China Brain Project
- The National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Ling, Y., Wen, X., Tang, J., Tao, Z., Sun, L., Xin, H., & Luo, B. (2024). Effect of topographic comparison of electroencephalographic microstates on the diagnosis and prognosis prediction of patients with prolonged disorders of consciousness. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14421
Vancouver
Ling Y, Wen X, Tang J, Tao Z, Sun L, Xin H, et al. Effect of topographic comparison of electroencephalographic microstates on the diagnosis and prognosis prediction of patients with prolonged disorders of consciousness. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14421
BibTeX
@article{Ling2024,
author = {Ling, Yi and Wen, Xinrui and Tang, Jianghui and Tao, Zhengde and Sun, Liping and Xin, Hailiang and Luo, Benyan},
title = {Effect of topographic comparison of electroencephalographic microstates on the diagnosis and prognosis prediction of patients with prolonged disorders of consciousness},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14421}
}
EUVIMED